Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $690,225 - $739,780
2,041 Added 283.87%
2,760 $959,000
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $4,087 - $4,574
13 Added 1.84%
719 $253,000
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $199,960 - $228,108
706 New
706 $222,000
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $517,146 - $643,902
-2,201 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $487,345 - $574,394
2,201 New
2,201 $574,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.